7/16/2024NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...

7/3/2024NMPA Announces Package Insert Revision of Dihydroxypropyl Theophylline...

6/17/2024NMPA Announces Package Insert Revision of Cyclophosphamide Adenosine, ...

6/14/2024CDE Issues the Technical Guidelines for the Assessment of Adverse Even...

5/28/2024NMPA Issues Announcement on Pediatric Use Info Addition to the Package...

4/1/2024NMPA Announces Package Insert Revision of Metronidazole Injection and ...

3/26/2024NMPA Publishes the 2023 Annual Report for Adverse Drug Reaction Monito...

3/22/2024NMPA Announces Package Insert Revision of Multiple Drugs

8/29/2023NMPA Announces Package Insert Revision of Two Drug Products

8/17/2023NMPA Announces Package Insert Revision of Three Drug Products

6/30/2023NMPA Solicits Comments on the Draft Technical Guidelines for Preparing...

6/13/2023NMPA Announces Package Insert Revision of Betahistine Preparations

4/25/2023NMPA Announces Package Insert Revision of Additional Two Drug Products

4/24/2023NMPA Announces Package Insert Revision of Multiple Drug Products

3/24/2023NMPA Publishes the 2022 Annual Report for Adverse Drug Reaction Monito...

1/16/2023NMPA Announces Package Insert Revision of Sodium Carbosulfate Formulat...

1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...

12/29/2022NMPA Announces Package Insert Revision of Prednisolone Inj, Pethidine ...

11/24/2022China Issues the National Action Plan for Containment of Microbiologic...

11/11/2022NMPA Announces Package Insert Revision of Phloroglucinol Injection

11/4/2022NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...

11/2/2022NMPA Announces Package Insert Revision of Liver Hydrolyzed Peptide Inj...

10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations

4/21/2022CDE Issues the Technical Guidelines for Adverse Drug Reaction Data Sum...

3/31/2022NMPA Publishes 2021 Annual Report for Adverse Drug Reaction Monitoring

1/26/2022NMPA Announces Package Insert Revision of Numerous Drug Products

11/26/2021CDE Solicits Comments the Guidelines for Evaluation of Immune-Related ...

10/4/2021China to Adopt Patient Reported Outcome Technology to Supplement Clini...

8/18/2021CDE Solicits Comments on the Technical Guidance for Adverse Drug React...

3/26/2021NMPA Publishes 2020 Annual Report for Adverse Drug Reaction Monitoring

Page:1/5 Total number of articles:122: [First][<<] [1] [2] [3] [4] [5] [>>] [End]